Literature DB >> 21454382

NAFLD and extrahepatic cancers: have a look at the colon.

Herbert Tilg1, Anna Mae Diehl.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21454382      PMCID： PMC3638235          DOI： 10.1136/gut.2011.239392

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  20 in total

Review 1.  Cytokines in alcoholic and nonalcoholic steatohepatitis.

Authors:  H Tilg; A M Diehl
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

2.  Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader; Gianfranco Pagano
Journal:  Ann Med       Date:  2010-11-02       Impact factor: 4.709

Review 3.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Nat Rev Immunol       Date:  2006-09-22       Impact factor: 53.106

4.  Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.

Authors:  Esther K Wei; Edward Giovannucci; Charles S Fuchs; Walter C Willett; Christos S Mantzoros
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

Review 5.  Obesity and gastrointestinal cancer.

Authors:  C L Donohoe; G P Pidgeon; J Lysaght; J V Reynolds
Journal:  Br J Surg       Date:  2010-05       Impact factor: 6.939

6.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

7.  A case-control study of non-alcoholic fatty liver disease in breast cancer.

Authors:  Ahmet Bilici; Mustafa Ozguroglu; Ismail Mihmanli; Hande Turna; Ibrahim Adaletli
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

8.  Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps.

Authors:  Sang Tae Hwang; Yong Kyun Cho; Jung Ho Park; Hong Joo Kim; Dong Il Park; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Kyoung Hee Won; Wook Jin
Journal:  J Gastroenterol Hepatol       Date:  2010-01-13       Impact factor: 4.029

Review 9.  Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events.

Authors:  Alireza Ansary Moghaddam; Mark Woodward; Rachel Huxley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

10.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

Authors:  Ebba Bråkenhielm; Niina Veitonmäki; Renhai Cao; Shinji Kihara; Yuji Matsuzawa; Boris Zhivotovsky; Tohru Funahashi; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205
View more
  15 in total

1.  Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Authors:  Ken Liu; Vincent Wai-Sun Wong; Keith Lau; Sienna Du Liu; Yee-Kit Tse; Terry Cheuk-Fung Yip; Raymond Kwok; Alex Yiu-Wa Chan; Henry Lik-Yuen Chan; Grace Lai-Hung Wong
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 2.  Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer.

Authors:  Kara Wegermann; Jeongeun Hyun; Anna Mae Diehl
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

Review 3.  Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

4.  Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study.

Authors:  Xian-Feng Lin; Ke-Qing Shi; Jie You; Wen-Yue Liu; Ying-Wan Luo; Fa-Ling Wu; Yong-Ping Chen; Danny Ka-Ho Wong; Man-Fung Yuen; Ming-Hua Zheng
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

5.  The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.

Authors:  Shuang Pan; Wandong Hong; Wenzhi Wu; Qinfen Chen; Qian Zhao; Jiansheng Wu; Yin Jin
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

6.  HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.

Authors:  Varun Chandrashekaran; Ratanesh K Seth; Diptadip Dattaroy; Firas Alhasson; Jacek Ziolenka; James Carson; Franklin G Berger; Balaraman Kalyanaraman; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Redox Biol       Date:  2017-05-10       Impact factor: 11.799

7.  High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease.

Authors:  Firas Alhasson; Ratanesh Kumar Seth; Sutapa Sarkar; Diana A Kimono; Muayad S Albadrani; Diptadip Dattaroy; Varun Chandrashekaran; Geoffrey I Scott; Samir Raychoudhury; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Redox Biol       Date:  2018-04-07       Impact factor: 11.799

8.  Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.

Authors:  Yoon Jin Choi; Dong Ho Lee; Kyung-Do Han; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  PLoS One       Date:  2018-09-19       Impact factor: 3.240

Review 9.  The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.

Authors:  Said O Muhidin; Ahmed A Magan; Khalid A Osman; Shareef Syed; Mohamed H Ahmed
Journal:  J Obes       Date:  2012-12-10

Review 10.  Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.

Authors:  Claudia Sanna; Chiara Rosso; Milena Marietti; Elisabetta Bugianesi
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.